NCT02209506View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
SafetyTolerabilityPharmacokineticsPharmacodynamics
Interventions
DRUG

MLN3126

MLN3126 tablets

DRUG

MLN3126 Matched Placebo

MLN3126 placebo-matching tablets

Trial Locations (1)

07753

Neptune City

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY